Staphylococcus aureus infection

Search with Google Search with Bing
Information
Disease name
Staphylococcus aureus infection
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04210505 Active, not recruiting Phase 4 Nasal Decolonization of Dialysis Patients Noses September 29, 2020 January 31, 2024
NCT01879761 Active, not recruiting Immune Resolution After Staphylococcus Aureus Bacteremia June 2013 June 2024
NCT01375621 Completed Livestock Contact and MRSA in Rural Areas June 1, 2011 May 21, 2020
NCT01792804 Completed Phase 3 Staphylococcus Aureus Bacteremia Antibiotic Treatment Options December 2013 March 26, 2020
NCT02282605 Completed Phase 1/Phase 2 Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects September 2014 November 2014
NCT04784312 Completed Phase 1 A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection April 16, 2021 August 17, 2021
NCT02804711 Completed Phase 1 A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults September 2016 September 2017
NCT02820883 Completed Early Phase 1 A Study of a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults June 2016 August 2016
NCT03966040 Completed Phase 1 A Clinical Trial to Evaluate a Recombinant Staphylococcus Aureus Vaccine (Escherichia Coli) in Healthy Adults May 16, 2019 May 16, 2020
NCT00572910 Completed Phase 2 A Study to Evaluate the Safety and Immunogenicity of V710 in Adults With Kidney Disease on Hemodialysis (V710-005)(COMPLETED) August 2008 January 2010
NCT04503252 Completed Probability of Target Attainment With Standard Intermittent Bolus Administration of Cefazolin in Patients With Complicated Infections Caused by Staphylococcus Aureus January 14, 2020 March 28, 2022
NCT04803708 Completed Phase 1/Phase 2 Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers March 22, 2021 September 5, 2022
NCT06317688 Enrolling by invitation Phase 1 Effectiveness of Highly Purified Anhydrous (HPA) Lanolin Versus Extra-Virgin Coconut Oil in Preventing Subacute Lactation Mastitis November 6, 2023 August 14, 2024
NCT04897971 Enrolling by invitation Serum Based Diagnosis of and Monitoring of Infection Recovery in Orthopedic Spine Implant Infections August 24, 2021 May 2026
NCT05361135 Not yet recruiting N/A 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia September 2023 July 2026
NCT05899140 Not yet recruiting Phase 4 Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial February 1, 2024 July 31, 2024
NCT06456424 Not yet recruiting Phase 1/Phase 2 Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection June 2024 June 2025
NCT06368856 Recruiting Phase 1 Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study February 29, 2024 March 2025
NCT06210594 Recruiting Phase 4 Staph Intervention for Effective Local Defense April 1, 2024 January 1, 2026
NCT06319235 Recruiting Phase 1/Phase 2 Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG® October 27, 2023 December 31, 2025
NCT05117398 Recruiting Phase 3 Dalbavancin Versus Standard Antibiotic Therapy for Catheter-related Bloodstream Infections Due to Staphylococcus Aureus June 23, 2023 September 23, 2026
NCT04712123 Unknown status Recurrent S. Aureus Infections in Osteoarticular Infections August 1, 2021 January 1, 2023
NCT00532324 Unknown status N/A Community-Acquired Methicillin Resistant Staphylococcus Aureus Colonization in Pregnant Women and Infections in Newborns January 2008 January 2010
NCT02741869 Withdrawn N/A Photodisinfection for the Decolonization of Staphylococcus Aureus in Hemodialysis Patients May 2016 December 1, 2016